About Index Trending news
Analyze
Pricing
SV Life Sciences

SV Life Sciences

SV Life Sciences

Life Sciences Venture Capital firm focused on selectively investing in biotech, medical devices and health-care services.

Elsewhere

Alexa global traffic share

Twitter followers

20 Mar 2017
$30,000,000
Venture capital (Series B)
SV Life Sciences, F-Prime Capital Partners, Johnson & Johnson, +2

British biotech Pulmocide raises £24m in bid to find treatment for deadly lung diseases

The Telegraph
+1
04 Jan 2017
$8,000,000
Venture capital (Series A)

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics

prnewswire
+1
01 Aug 2016
$11,890,000
Venture capital (Series A)

Aligned TeleHealth takes in $12 mln Series A

PE Hub
+1
15 Jan 2015
$12,400,000
Venture capital (Series A)
08 Dec 2014
09 May 2014
14 Nov 2013
11 Sep 2013
$11,900,000
Debt financing
SV Life Sciences, Oxford Bioscience Partners, Forward Ventures
03 Apr 2012
02 Apr 2012